These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7508022)

  • 1. Properties of the purified hypothalamic pituitary NA/K-ATPase inhibitor.
    Sancho JM; Garcia-Martin E; Garcia-Robles R; Santirso R; Villa E; Gutierrez-Merino C; Ricote M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S32-4. PubMed ID: 7508022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain.
    Sancho JM
    Clin Exp Hypertens; 1998; 20(5-6):535-42. PubMed ID: 9682909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic factor inhibits the (Na,K)ATPase from the extracellular surface. Mechanism of inhibition.
    Carilli CT; Berne M; Cantley LC; Haupert GT
    J Biol Chem; 1985 Jan; 260(2):1027-31. PubMed ID: 2981828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two brain inhibitors inhibit renal Na,K-ATPases without recognizing the species-dependent variation of their ouabain-sensitivity.
    Anner BM
    Clin Exp Hypertens; 1998; 20(5-6):489-97. PubMed ID: 9682905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Na+ pump in renal tubular cells is regulated by endogenous Na+-K+-ATPase inhibitor from hypothalamus.
    Cantiello HF; Chen E; Ray S; Haupert GT
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F574-80. PubMed ID: 2845805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel endogenous sodium-pump inhibitor in pig urine: purification and comparison with the inhibitor purified from bovine adrenal glands.
    Tamura M; Konishi F; Inagami T
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S47-50. PubMed ID: 7508027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and properties of endogenous ouabain-like substances from hemofiltrate and adrenal glands.
    Schoner W; Heidrich-Lorsbach E; Kirch U; Ahlemeyer B; Sich B
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S29-31. PubMed ID: 7508021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of a (Na+-K+)-ATPase inhibitor in extracts of tea.
    Sagnella GA; MacGregor GA
    Am J Clin Nutr; 1984 Jul; 40(1):36-41. PubMed ID: 6331148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
    Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
    Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a sodium pump inhibitor from human plasma.
    Hamlyn JM; Harris DW; Clark MA; Rogowski AC; White RJ; Ludens JH
    Hypertension; 1989 Jun; 13(6 Pt 2):681-9. PubMed ID: 2544519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete purification of two identical Na(+)-pump inhibitors isolated from bovine hypothalamus and hypophysis.
    Illescas M; Ricote M; Mendez E; G-Robles R; Sancho J
    FEBS Lett; 1990 Feb; 261(2):436-40. PubMed ID: 2155831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus.
    Tymiak AA; Norman JA; Bolgar M; DiDonato GC; Lee H; Parker WL; Lo LC; Berova N; Nakanishi K; Haber E
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8189-93. PubMed ID: 8396262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(NA++K+)-ATPase inhibitor from bovine hypothalamus].
    Fu Y
    Zhonghua Yi Xue Za Zhi; 1990 Aug; 70(8):442-5, 32. PubMed ID: 2174283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of specific endogenous ouabainlike substance from bovine adrenal.
    Inagami T; Tamura M
    Am J Med Sci; 1988 Apr; 295(4):400-5. PubMed ID: 2834953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.